Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Buy
10,970
+8,303
+311% +$972K 0.35% 55
2026
Q1
$321K Hold
2,667
0.3% 62
2025
Q4
$281K Buy
+2,667
New +$250K 0.27% 68
2025
Q2
$286K Sell
3,616
-4,416
-55% -$351K 0.28% 69
2025
Q1
$721K Sell
8,032
-1,498
-16% -$140K 0.47% 51
2024
Q4
$948K Buy
9,530
+287
+3% +$29.6K 0.61% 39
2024
Q3
$1.05M Sell
9,243
-328
-3% -$39K 0.7% 36
2024
Q2
$1.19M Sell
9,571
-110
-1% -$14.2K 0.85% 27
2024
Q1
$1.28M Buy
+9,681
New +$1.19M 0.96% 25

Other funds holding MRK

Wealth Group's MRK Position: Q2 2026 in Review

Wealth Group increased its Merck (MRK) stake by 311% in Q2 2026, buying an estimated $972K and bringing the position to 10,970 shares worth $1.41M. The position accounts for 0.35% of the portfolio, ranked #55.

Wealth Group first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wealth Group held 10,970 shares of Merck worth $1.41M as of Q2 2026.
  • Wealth Group bought 8,303 Merck shares in Q2 2026, an estimated $972K.
  • Merck made up 0.35% of Wealth Group's portfolio in Q2 2026, its #55 holding.
  • Wealth Group first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.